These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 33396786)

  • 21. Recent advances in the characterization of amorphous pharmaceuticals by X-ray diffractometry.
    Thakral S; Terban MW; Thakral NK; Suryanarayanan R
    Adv Drug Deliv Rev; 2016 May; 100():183-93. PubMed ID: 26712710
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vitro characterization of a novel polymeric system for preparation of amorphous solid drug dispersions.
    Mahmoudi ZN; Upadhye SB; Ferrizzi D; Rajabi-Siahboomi AR
    AAPS J; 2014 Jul; 16(4):685-97. PubMed ID: 24789531
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Direct Visualization of Drug-Polymer Phase Separation in Ritonavir-Copovidone Amorphous Solid Dispersions Using
    Shi C; Li L; Zhang GGZ; Borchardt TB
    Mol Pharm; 2019 Nov; 16(11):4751-4754. PubMed ID: 31553871
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Development of stability-enhanced ternary solid dispersions via combinations of HPMCP and Soluplus
    Albadarin AB; Potter CB; Davis MT; Iqbal J; Korde S; Pagire S; Paradkar A; Walker G
    Int J Pharm; 2017 Oct; 532(1):603-611. PubMed ID: 28923766
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Kinetic products in coordination networks: ab initio X-ray powder diffraction analysis.
    Martí-Rujas J; Kawano M
    Acc Chem Res; 2013 Feb; 46(2):493-505. PubMed ID: 23252592
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Monitoring Polymorphic Phase Transitions in Flufenamic Acid Amorphous Solid Dispersions Using Hyphenated X-ray Diffraction-Differential Scanning Calorimetry.
    Pang Y; Buanz A; Gaisford S; Magdysyuk OV; Williams GR
    Mol Pharm; 2022 May; 19(5):1477-1487. PubMed ID: 35347993
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Understanding Molecular Interactions in Rafoxanide-Povidone Amorphous Solid Dispersions from Ultrafast Magic Angle Spinning NMR.
    Li M; Meng F; Tsutsumi Y; Amoureux JP; Xu W; Lu X; Zhang F; Su Y
    Mol Pharm; 2020 Jun; 17(6):2196-2207. PubMed ID: 32392076
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Application of X-ray Diffraction and Electron Crystallography for Solving Complex Structure Problems.
    Li J; Sun J
    Acc Chem Res; 2017 Nov; 50(11):2737-2745. PubMed ID: 29091406
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Probing the Molecular-Level Interactions in an Active Pharmaceutical Ingredient (API) - Polymer Dispersion and the Resulting Impact on Drug Product Formulation.
    Yang F; Su Y; Small J; Huang C; Martin GE; Farrington AM; DiNunzio J; Brown CD
    Pharm Res; 2020 May; 37(6):94. PubMed ID: 32405662
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Quantitative Measures of Crystalline Fenofibrate in Amorphous Solid Dispersion Formulations by X-Ray Microscopy.
    Neilly JP; Yin L; Leonard SE; Kenis PJA; Danzer GD; Pawate AS
    J Pharm Sci; 2020 Oct; 109(10):3078-3085. PubMed ID: 32679216
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characterization of Phase Separation Propensity for Amorphous Spray Dried Dispersions.
    McNamara D; Yin S; Pan D; Crull G; Timmins P; Vig B
    Mol Pharm; 2017 Feb; 14(2):377-385. PubMed ID: 28068097
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Spray-Dried Paracetamol/Polyvinylpyrrolidone Amorphous Solid Dispersions: Part I-Stability of Powders and Tablets.
    Ritters L; Tian Y; Reichl S
    Pharmaceutics; 2021 Nov; 13(11):. PubMed ID: 34834353
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Five-Stage Approach for a Systematic Screening and Development of Etravirine Amorphous Solid Dispersions by Hot-Melt Extrusion.
    Simões MF; Pereira A; Cardoso S; Cadonau S; Werner K; Pinto RMA; Simões S
    Mol Pharm; 2020 Feb; 17(2):554-568. PubMed ID: 31774685
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Investigation of Drug-Excipient Interactions in Biclotymol Amorphous Solid Dispersions.
    Schammé B; Couvrat N; Tognetti V; Delbreilh L; Dupray V; Dargent É; Coquerel G
    Mol Pharm; 2018 Mar; 15(3):1112-1125. PubMed ID: 29328661
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Local Structure of Ion Pair Interaction in Lapatinib Amorphous Dispersions characterized by Synchrotron X-Ray diffraction and Pair Distribution Function Analysis.
    de Araujo GL; Benmore CJ; Byrn SR
    Sci Rep; 2017 Apr; 7():46367. PubMed ID: 28397829
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Use of Terahertz-Raman Spectroscopy to Determine Solubility of the Crystalline Active Pharmaceutical Ingredient in Polymeric Matrices during Hot Melt Extrusion.
    Bordos E; Islam MT; Florence AJ; Halbert GW; Robertson J
    Mol Pharm; 2019 Oct; 16(10):4361-4371. PubMed ID: 31436094
    [TBL] [Abstract][Full Text] [Related]  

  • 37. X-ray Absorption Near-Edge Spectroscopy Analysis of Indomethacin in Crystalline Forms and in Amorphous Solid Dispersions.
    Suzuki H; Iwata M; Ito M; Noguchi S
    Mol Pharm; 2021 Sep; 18(9):3475-3483. PubMed ID: 34372659
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Drug Release and Nanodroplet Formation from Amorphous Solid Dispersions: Insight into the Roles of Drug Physicochemical Properties and Polymer Selection.
    Yang R; Mann AKP; Van Duong T; Ormes JD; Okoh GA; Hermans A; Taylor LS
    Mol Pharm; 2021 May; 18(5):2066-2081. PubMed ID: 33784104
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Investigating the effect of moisture protection on solid-state stability and dissolution of fenofibrate and ketoconazole solid dispersions using PXRD, HSDSC and Raman microscopy.
    Kanaujia P; Lau G; Ng WK; Widjaja E; Schreyer M; Hanefeld A; Fischbach M; Saal C; Maio M; Tan RB
    Drug Dev Ind Pharm; 2011 Sep; 37(9):1026-35. PubMed ID: 21417604
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The role of the carrier in the formulation of pharmaceutical solid dispersions. Part II: amorphous carriers.
    Van Duong T; Van den Mooter G
    Expert Opin Drug Deliv; 2016 Dec; 13(12):1681-1694. PubMed ID: 27267583
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.